Y-Mabs Therapeutics Inc (YMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Operating Expenses | 83,004 | 43,230 | 19,244 | 17,039 | 0 |
| Operating Income | -83,004 | -43,230 | -19,244 | -17,039 | N/A |
| Other Income | 1,976 | -44 | 83 | -18 | 0 |
| Pre-tax Income | -81,028 | -43,274 | -19,161 | -17,057 | 0 |
| Net Income Continuous | -81,028 | -43,274 | -19,161 | -17,057 | N/A |
| Net Income | $-81,028 | $-43,274 | $-19,161 | $-17,057 | $N/A |
| EPS Basic Total Ops | -2.30 | -1.50 | -0.99 | -1.21 | N/A |
| EPS Basic Continuous Ops | -2.30 | -1.50 | -0.99 | -1.21 | N/A |
| EPS Diluted Total Ops | -2.30 | -1.50 | -0.99 | -1.21 | N/A |
| EPS Diluted Continuous Ops | -2.30 | -1.50 | -0.99 | -1.21 | N/A |
| EPS Diluted Before Non-Recurring Items | -2.30 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-82,838 | $-43,201 | $-19,244 | $-17,039 | $N/A |